ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	6/131	79/7206	0.00302260010741
ko00250	Alanine, aspartate and glutamate metabolism	4/131	38/7206	0.00477211744796
ko00330	Arginine and proline metabolism	5/131	61/7206	0.00484677629954
ko04260	Cardiac muscle contraction	6/131	98/7206	0.00865777579348
ko05100	Bacterial invasion of epithelial cells	6/131	99/7206	0.00908230234103
ko00564	Glycerophospholipid metabolism	6/131	99/7206	0.00908230234103
ko05146	Amoebiasis	6/131	99/7206	0.00908230234103
ko05410	Hypertrophic cardiomyopathy (HCM)	6/131	100/7206	0.00952154622554
ko04510	Focal adhesion	10/131	240/7206	0.0118198441877
ko00590	Arachidonic acid metabolism	4/131	52/7206	0.0144065694887
ko05414	Dilated cardiomyopathy	6/131	112/7206	0.0160353929354
ko00280	Valine, leucine and isoleucine degradation	4/131	54/7206	0.0163698700923
ko05416	Viral myocarditis	4/131	55/7206	0.0174114046974
ko00361	Chlorocyclohexane and chlorobenzene degradation	1/131	1/7206	0.0181792950319
ko00364	Fluorobenzoate degradation	1/131	1/7206	0.0181792950319
ko00623	Toluene degradation	1/131	1/7206	0.0181792950319
ko04392	Hippo signaling pathway -multiple species	3/131	31/7206	0.0182089907351
ko00760	Nicotinate and nicotinamide metabolism	3/131	34/7206	0.0233073190988
ko05110	Vibrio cholerae infection	4/131	63/7206	0.0272341700522
ko05132	Salmonella infection	5/131	98/7206	0.0326064638835
ko03320	PPAR signaling pathway	4/131	69/7206	0.0364010752077
ko02020	Two-component system	2/131	17/7206	0.0373228436972
ko04214	Apoptosis - fly	4/131	72/7206	0.0415763374906
ko00071	Fatty acid degradation	3/131	45/7206	0.0479016328244